News - BioPharm International

ADVERTISEMENT

News

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates

July 1, 2014

The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.

FDA Outlines Guidance and Rules for Compounding Drug Products

July 1, 2014

FDA releases guidance documents and rules on requirements for compounding human drug products.

FDA Issues Warning Letter to GSK Biologicals

June 26, 2014

GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.

More than 430 New Medicines in Development for Chronic Diseases

June 26, 2014

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

Medicenna Therapeutics Selects Kalon Biotherapeutics To Manufacture New Cancer Drug

June 26, 2014

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

FDA Approves Antibiotic Treatment

June 25, 2014

FDA approved Cubist's treatment for skin infections including MRSA.

National Bioscience Report Reveals Positive Trends for Bioscience Industry

June 25, 2014

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

Shire Confirms Rejection of AbbVie Proposal

June 20, 2014

Shire reports that AbbVie offer undervalued company.

FDA Issues Warning Letter to API Manufacturer Apotex Pharmachem India

June 18, 2014

FDA inspection found cGMP violations in the Bangalore, India API manufacturing facility.

ADVERTISEMENT

ADVERTISEMENT

Click here